The endocannabinoid system in critical neurodevelopmental periods: Sex differences and neuropsychiatric implications

Journal of Psychopharmacology

Volumn 26, Issue 1, 2012, Pages 164-176

  Viveros, M P ^a   Llorente, R ^a   Suarez, J ^b   Llorente Berzal, A ^a   Lopez Gallardo M ^a   Rodriguez De Fonseca, F ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Adolescence; animal models; cannabinoid receptors; early life stress; neuropsychiatric disorders; sexual dimorphisms

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINOBUTYRIC ACID RECEPTOR; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; DIZOCILPINE; ENDOCANNABINOID;

BRAIN DEVELOPMENT; BRAIN MATURATION; DEPRESSION; DRUG ABUSE; ENZYME DEGRADATION; EPIGENETICS; IMMUNOREACTIVITY; LONG TERM MEMORY; MATERNAL DEPRIVATION; MEDICAL RESEARCH; MENTAL DISEASE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NEUROPSYCHIATRY; NONHUMAN; NUCLEUS ACCUMBENS; PHENOTYPE; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SOCIAL ADAPTATION; SOCIAL BEHAVIOR; SOCIAL INTERACTION; WORKING MEMORY;

ANIMALS; BRAIN; ENDOCANNABINOIDS; HUMANS; MENTAL DISORDERS; SEX CHARACTERISTICS; SUBSTANCE-RELATED DISORDERS;

EID: 84856410129     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881111408956     Document Type: Review

References (131)

1. Adriani W, Laviola G. Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model. Behav Pharmacol. 2004 ; 15: 341-352 (Pubitemid 39238344)
2. Agrawal A, Neale MC, Prescott CA, et al. Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. Behav Genet. 2004 ; 34: 217-228 (Pubitemid 38437619)
3. Asúa T, Bilbao A, Gorriti MA, et al. Implication of the endocannabinoid system in the locomotor hyperactivity associated with congenital hypothyroidism. Endocrinology. 2008 ; 149: 2657-2666 (Pubitemid 351574500)
4. Belue RC, Howlett AC, Westlake TM, et al. The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol Teratol. 1995 ; 17: 25-30
5. Berghuis P, Dobszay MB, Wang X, et al. Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc Natl Acad Sci U S A. 2005 ; 102: 19115-19120 (Pubitemid 43049575)
6. Bermudez-Silva FJ, Viveros MP, McPartland JM, et al. The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning?. Pharmacol Biochem Behav. 2010 ; 95: 375-382
7. Bhattacharyya S, Morrison PD, Fusar-Poli P, et al. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology. 2010 ; 35: 764-774
8. Biscaia M, Fernandez B, Higuera-Matas A, et al. Sex-dependent effects of periadolescent exposure to the cannabinoid agonist CP-55,940 on morphine self-administration behaviour and the endogenous opioid system. Neuropharmacology. 2008 ; 54: 863-873
9. Biscaia M, Marin S, Fernandez B, et al. Chronic treatment with CP 55,940 during the peri-adolescent period differentially affects the behavioural responses of male and female rats in adulthood. Psychopharmacology (Berl). 2003 ; 170: 301-308 (Pubitemid 37491610)
10. Bisogno T, Howell F, Williams G, et al. Cloning of the first SN1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol. 2003 ; 163: 463-468 (Pubitemid 37429860)
11. Blankman JL, Simon GM, Cravatt BF. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol. 2007 ; 14: 1347-1356 (Pubitemid 350257008)
12. Cota D. The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity. J Neuroendocrinol. 2008 ; 20: 35-38 (Pubitemid 351552674)
13. Crews F, He J, Hodge C. Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav. 2007 ; 86: 189-199 (Pubitemid 46282057)
14. Dean B, Sundram S, Bradbury R, et al. Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use. Neuroscience. 2001 ; 103: 9-15 (Pubitemid 32304342)
15. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction. 2003 ; 98: 1493-1504 (Pubitemid 37373847)
16. del Arco I, Muñoz R, Rodríguez de Fonseca F, et al. Maternal exposure to the synthetic cannabinoid HU-210: effects on the endocrine and immune systems of the adult male offspring. Neuroimmunomodulation. 2000 ; 7: 16-26 (Pubitemid 30012575)
17. Di Chiara G. Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res. 2002 ; 137: 75-114 (Pubitemid 35346430)
18. Di Forti M, Morgan C, Dazzan P, et al. High-potency cannabis and the risk of psychosis. Br J Psychiatry. 2009 ; 195: 488-491
19. Di Forti M, Morrison PD, Butt A, et al. Cannabis use and psychiatric and cognitive disorders: the chicken or the egg?. Curr Opin Psychiatry. 2007 ; 20: 228-234 (Pubitemid 46588294)
20. Ellenbroek BA, de Bruin NM, van Den Kroonenburg PT, et al. The effects of early maternal deprivation on auditory information processing in adult Wistar rats. Biol Psychiatry. 2004 ; 55: 701-707 (Pubitemid 38376181)
21. Ellenbroek BA, Riva MA. Early maternal deprivation as an animal model for schizophrenia. Clin Neurosci Res. 2003 ; 3: 297-302 (Pubitemid 37461295)
22. Ellgren M, Artmann A, Tkalych O, et al. Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur Neuropsychopharmacol. 2008 ; 18: 826-834
23. Ellgren M, Spano SM, Hurd YL. Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology. 2007 ; 32: 607-615
24. Fatemi SH, Folsom TD. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull. 2009 ; 35: 528-548
25. Fattore L, Fadda P, Fratta W. Sex differences in the self-administration of cannabinoids and other drugs of abuse. Psychoneuroendocrinology. 2009 ; 34 (Suppl 1). S227 - S236
26. Fattore L, Spano MS, Altea S, et al. Cannabinoid self-administration in rats: sex differences and the influence of ovarian function. Br J Pharmacol. 2007 ; 152: 795-804 (Pubitemid 350034986)
27. Fernandez-Espejo E, Viveros MP, Nunez L, et al. Role of cannabis and endocannabinoids in the genesis of schizophrenia. Psychopharmacology (Berl). 2009 ; 206: 531-549
28. Fernández-González R, Moreira P, Bilbao A, et al. Long-term effect of in vitro culture of mouse embryos with serum on mRNA expression of imprinting genes, development, and behavior. Proc Natl Acad Sci U S A. 2004 ; 101: 5880-5885 (Pubitemid 38520497)
29. Fernandez-Ruiz J, Gomez M, Hernandez M, et al. Cannabinoids and gene expression during brain development. Neurotox Res. 2004 ; 6: 389-401
30. Ferraro L, Tomasini MC, Beggiato S, et al. Short- and long-term consequences of prenatal exposure to the cannabinoid agonist WIN55,212-2 on rat glutamate transmission and cognitive functions. J Neural Transm. 2009 ; 116: 1017-1027
31. Fiskerstrand T, H'mida-Ben Brahim D, Johansson S, et al. Mutations in ABHD12 cause the neurodegenerative disease PHARC: an inborn error of endocannabinoid metabolism. Am J Hum Genet. 2010 ; 87: 410-417
32. Franklin TB, Russig H, Weiss IC, et al. Epigenetic transmission of the impact of early stress across generations. Biol Psychiatry. 2010 ; 68: 408-415
33. Galve-Roperh I, Aguado T, Palazuelos J, et al. Mechanisms of control of neuron survival by the endocannabinoid system. Curr Pharm Des. 2008 ; 14: 2279-2288
34. García-Gutiérrez MS, Pérez-Ortiz JM, Gutiérrez-Adán A, et al. Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors. Br J Pharmacol. 2010 ; 160: 1773-1784
35. Giedd JN, Blumenthal J, Jeffries NO, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci. 1999 ; 2: 861-863 (Pubitemid 30602596)
36. Giedd JN, Keshavan M, Paus T. Why do many psychiatric disorders emerge during adolescence?. Nat Rev Neurosci. 2008 ; 9: 947-957
37. Giuffrida A, Leweke FM, Gerth CW, et al. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology. 2004 ; 29: 2108-2114 (Pubitemid 39486563)
38. Gogtay N, Giedd JN, Lusk L, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A. 2004 ; 101: 8174-8179 (Pubitemid 38698073)
39. Goncalves MB, Suetterlin P, Yip P, et al. A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner. Mol Cell Neurosci. 2008 ; 38: 526-536
40. Gonzalez S, Bisogno T, Wenger T, et al. Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland. Biochem Biophys Res Commun. 2000 ; 270: 260-266 (Pubitemid 30440425)
41. Greenfield SF, Back SE, Lawson K, et al. Substance abuse in women. Psychiatr Clin North Am. 2010 ; 33: 339-355
42. Hajos M, Hoffmann WE, Kocsis B. Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry. 2008 ; 63: 1075-1083
43. Handa RJ, Pak TR, Kudwa AE, et al. An alternate pathway for androgen regulation of brain function: activation of estrogen receptor beta by the metabolite of dihydrotestosterone, 5alpha-androstane-3beta,17beta-diol. Horm Behav. 2008 ; 53: 741-752
44. Harkany T, Guzman M, Galve-Roperh I, et al. The emerging functions of endocannabinoid signaling during CNS development. Trends Pharmacol Sci. 2007 ; 28: 83-92 (Pubitemid 46161836)
45. Harkany T, Keimpema E, Barabas K, et al. Endocannabinoid functions controlling neuronal specification during brain development. Mol Cell Endocrinol. 2008a ; 286: S84 - S90
46. Harkany T, Mackie K, Doherty P. Wiring and firing neuronal networks: endocannabinoids take center stage. Curr Opin Neurobiol. 2008b ; 18: 338-345
47. Higuera-Matas A, Soto-Montenegro ML, del Olmo N, et al. Augmented acquisition of cocaine self-administration and altered brain glucose metabolism in adult female but not male rats exposed to a cannabinoid agonist during adolescence. Neuropsychopharmacology. 2008 ; 33: 806-813 (Pubitemid 351252702)
48. Ishiguro H, Horiuchi Y, Ishikawa M, et al. Brain cannabinoid CB2 receptor in schizophrenia. Biol Psychiatry. 2010 ; 67: 974-982
49. Jernigan TL, Trauner DA, Hesselink JR, et al. Maturation of human cerebrum observed in vivo during adolescence. Brain. 1991 ; 114: 2037-2049
50. Labrie V, Roder JC. The involvement of the NMDA receptor D-serine/glycine site in the pathophysiology and treatment of schizophrenia. Neurosci Biobehav Rev. 2010 ; 34: 351-372
51. Larkin AE, Fahey B, Gobbo O, et al. Blockade of NMDA receptors pre-training, but not post-training, impairs object displacement learning in the rat. Brain Res. 2008 ; 1199: 126-132
52. Laviola G, Macri S, Morley-Fletcher S, et al. Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci Biobehav Rev. 2003 ; 27: 19-31 (Pubitemid 36535388)
53. Levine S. Developmental determinants of sensitivity and resistance to stress. Psychoneuroendocrinology. 2005 ; 30: 939-946 (Pubitemid 40982476)
54. Leweke FM, Giuffrida A, Koethe D, et al. Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: impact of cannabis use. Schizophr Res. 2007 ; 94: 29-36 (Pubitemid 47031599)
55. Leweke FM, Giuffrida A, Wurster U, et al. Elevated endogenous cannabinoids in schizophrenia. Neuroreport. 1999 ; 10: 1665-1669 (Pubitemid 29354290)
56. Leweke FM, Koethe D. Cannabis and psychiatric disorders: it is not only addiction. Addict Biol. 2008 ; 13: 264-275 (Pubitemid 351692982)
57. Leweke FM, Schneider M. Chronic pubertal cannabinoid treatment as a behavioural model for aspects of schizophrenia: effects of the atypical antipsychotic quetiapine. Int J Neuropsychopharmacol. 2011 ; 14: 43-51
58. Lewis DA, Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci. 2002 ; 25: 409-432 (Pubitemid 34748023)
59. Lichtman AH, Blankman JL, Cravatt BF. Endocannabinoid overload. Mol Pharmacol. 2010 ; 78: 993-995
60. Llorente R, Arranz L, Marco EM, et al. Early maternal deprivation and neonatal single administration with a cannabinoid agonist induce long-term sex-dependent psychoimmunoendocrine effects in adolescent rats. Psychoneuroendocrinology. 2007 ; 32: 636-650 (Pubitemid 47018322)
61. Llorente R, Gallardo ML, Berzal AL, et al. Early maternal deprivation in rats induces gender-dependent effects on developing hippocampal and cerebellar cells. Int J Dev Neurosci. 2009 ; 27: 233-241
62. Llorente R, Llorente-Berzal A, Petrosino S, et al. Gender-dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: a possible role for the endocannabinoid system. Dev Neurobiol. 2008 ; 68: 1334-1347
63. López-Gallardo M, Llorente R, Llorente-Berzal A, et al. Neuronal and glial alterations in the cerebellar cortex of maternally deprived rats: gender differences and modulatory effects of two inhibitors of endocannabinoid inactivation. Dev Neurobiol. 2008 ; 68: 1429-1440
64. Lynskey MT, Heath AC, Bucholz KK, et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA. 2003 ; 289: 427-433 (Pubitemid 36119962)
65. Mackie K Cannabinoids. Handbook of Experimental Pharmacology. Pertwee RG, ed. Berlin: Springer ; 2005: 299-323.
66. Mackie K. Cannabinoid receptors: where they are and what they do. J Neuroendocrinol. 2008 ; 20 (Suppl 1). 10-14
67. Mailleux P, Vanderhaeghen JJ. Glucocorticoid regulation of cannabinoid receptor messenger RNA levels in the rat caudate-putamen. An in situ hybridization study. Neurosci Lett. 1993 ; 156: 51-53 (Pubitemid 23214722)
68. Malone DT, Hill MN, Rubino T. Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. Br J Pharmacol. 2010 ; 160: 511-522
69. Marco EM, Viveros MP. The critical role of the endocannabinoid system in emotional homeostasis: avoiding excess and deficiencies. Mini Rev Med Chem. 2009 ; 9: 1407-1415
70. Marco EM, Adriani W, Canese R, et al. Enhancement of endocannabinoid signalling during adolescence: Modulation of impulsivity and long-term consequences on metabolic brain parameters in early maternally deprived rats. Pharmacol Biochem Behav. 2007a ; 86: 334-345 (Pubitemid 46282052)
71. Marco EM, Granstrem O, Moreno E, et al. Subchronic nicotine exposure in adolescence induces long-term effects on hippocampal and striatal cannabinoid-CB1 and mu-opioid receptors in rats. Eur J Pharmacol. 2007b ; 557: 37-43 (Pubitemid 46135558)
72. Marco EM, Llorente R, Moreno E, et al. Adolescent exposure to nicotine modifies acute functional responses to cannabinoid agonists in rats. Behav Brain Res. 2006 ; 172: 46-53 (Pubitemid 44063551)
73. Marek G, Merchant K. Developing therapeutics for schizophrenia and other psychotic disorders. NeuroRx. 2005 ; 2: 579-589 (Pubitemid 41393267)
74. Marrs WR, Blankman JL, Horne EA, et al. The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci. 2010 ; 13: 951-957
75. Mateos B, Borcel E, Loriga R, et al. Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB1 cannabinoid receptors. J Psychopharmacol. 2010 ; 25: 1676-1690
76. Mato S, Del Olmo E, Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur J Neurosci. 2003 ; 17: 1747-1754 (Pubitemid 36645324)
77. McCarthy MM. Estradiol and the developing brain. Physiol Rev. 2008 ; 88: 91-124
78. Mereu G, Fa M, Ferraro L, et al. Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci U S A. 2003 ; 100: 4915-4920 (Pubitemid 36457828)
79. Moffett MC, Vicentic A, Kozel M, et al. Maternal separation alters drug intake patterns in adulthood in rats. Biochem Pharmacol. 2007 ; 73: 321-330 (Pubitemid 44958363)
80. Moreira FA, Lutz B. The endocannabinoid system: emotion, learning and addiction. Addict Biol. 2008 ; 13: 196-212 (Pubitemid 351698889)
81. Moreno M, Escuredo L, Muñoz R, et al. Long-term behavioural and neuroendocrine effects of perinatal activation or blockade of CB1 cannabinoid receptors. Behav Pharmacol. 2005 ; 16: 423-430 (Pubitemid 41404814)
82. Mulder J, Aguado T, Keimpema E, et al. Endocannabinoid signaling controls piramidal cell specification and long-range axon patterning. Proc Natl Acad Sci U S A. 2008 ; 105: 8760-8765 (Pubitemid 351987753)
83. Nelson EE, Leibenluft E, McClure EB, et al. The social re-orientation of adolescence: a neuroscience perspective on the process and its relation to psychopathology. Psychol Med. 2005 ; 35: 163-174 (Pubitemid 40259909)
84. Nordentoft M, Hjorthoj C. Cannabis use and risk of psychosis in later life. Lancet. 2007 ; 370: 293-294 (Pubitemid 47096843)
85. O'Shea M, McGregor IS, Mallet PE. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. J Psychopharmacol. 2006 ; 20: 611-621 (Pubitemid 44315859)
86. O'Shea M, Singh ME, McGregor IS, et al. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol. 2004 ; 18: 502-508 (Pubitemid 39665118)
87. Paus T. Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci. 2005 ; 9: 60-68 (Pubitemid 40164471)
88. Pfefferbaum A, Mathalon DH, Sullivan EV, et al. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol. 1994 ; 51: 874-887 (Pubitemid 24286042)
89. Pope HG, Gruber AJ, Hudson JI, et al. Early-onset cannabis use and cognitive deficits: what is the nature of the association?. Drug Alcohol Depend. 2003 ; 69: 303-310 (Pubitemid 36293942)
90. Pope HG, Jacobs A, Mialet JP, et al. Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychother Psychosom. 1997 ; 66: 179-184 (Pubitemid 27331200)
91. Quinn HR, Matsumoto I, Callaghan PD, et al. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology. 2008 ; 33: 1113-1126 (Pubitemid 351367534)
92. Reich CG, Taylor ME, McCarthy MM. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behav Brain Res. 2009 ; 203: 264-269
93. Roche M, Finn DP. Brain CB2 receptors: implications for neuropsychiatric disorders. Pharmaceuticals. 2010 ; 3: 2517-2553
94. Rodriguez de Fonseca F, Cebeira M, Ramos JA, et al. Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement. Life Sci. 1994 ; 54: 159-170
95. Rodriguez de Fonseca F, Ramos JA, Bonnin A, et al. Presence of cannabinoid binding sites in the brain from early postnatal ages. Neuroreport. 1993 ; 4: 135-138 (Pubitemid 23080859)
96. Rodriguez de Fonseca F, Rubio P, Menzaghi F, et al. Corticotropin- releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37] CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats. J Pharmacol Exp Ther. 1996 ; 276: 56-64
97. RubinoTViganoDRealiniN. (2008) Chronic [Delta]9-Tetrahydrocannabinol During Adolescence Provokes Sex-Dependent Changes in the Emotional Profile in Adult Rats: Behavioral and Biochemical Correlates. Neuropsychopharmacology33: 2760-2771.
98. Rubino T, Realini N, Braida D, et al. Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus. 2009 ; 19: 763-772
99. Rubio P, Rodríguez de Fonseca F, Muñoz RM, et al. Long-term behavioral effects of perinatal exposure to delta 9-tetrahydrocannabinol in rats: possible role of pituitary-adrenal axis. Life Sci. 1995 ; 56: 2169-2176
100. Results from the 2008 National Survey on Drug Use and Health: National Findings. North Carolina, USA: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies ; 2008 :
101. Schneider M, Koch M. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology. 2003 ; 28: 1760-1769 (Pubitemid 41070841)
102. Schneider M, Koch M. The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion. Eur Neuropsychopharmacol. 2007 ; 17: 180-186 (Pubitemid 44779191)
103. Schneider M, Schomig E, Leweke FM. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats. Addict Biol. 2008 ; 13: 345-357
104. Schulz KM, Molenda-Figueira HA, Sisk CL. Back to the future: The organizational-activational hypothesis adapted to puberty and adolescence. Horm Behav. 2009 ; 55: 597-604
105. Schwarz JM, McCarthy MM. Steroid-induced sexual differentiation of the developing brain: multiple pathways, one goal. J Neurochem. 2008 ; 105: 1561-1572 (Pubitemid 351678518)
106. Shaw P, Greenstein D, Lerch J, et al. Intellectual ability and cortical development in children and adolescents. Nature. 2006 ; 440: 676-679
107. Solowij N, Michie PT. Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?. J Psychiatry Neurosci. 2007 ; 32: 30-52
108. Solowij N, Stephens RS, Roffman RA, et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA. 2002 ; 287: 1123-1131 (Pubitemid 34252081)
109. Sowell ER, Thompson PM, Holmes CJ, et al. In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat Neurosci. 1999 ; 2: 859-861 (Pubitemid 30602595)
110. Spano MS, Ellgren M, Wang X, et al. Prenatal cannabis exposure increases heroin seeking with allostatic changes in limbic enkephalin systems in adulthood. Biol Psychiatry. 2007 ; 61: 554-563 (Pubitemid 46185333)
111. Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev. 2000 ; 24: 417-463 (Pubitemid 30243061)
112. Suarez J, Llorente R, Romero-Zerbo SY, et al. Early maternal deprivation induces gender-dependent changes on the expression of hippocampal CB(1) and CB(2) cannabinoid receptors of neonatal rats. Hippocampus. 2009 ; 19: 623-632
113. Suárez J, Rivera P, Llorente R, et al. Early maternal deprivation induces changes on the expression of 2-AG biosynthesis and degradation enzymes in neonatal rat hippocampus. Brain Res. 2010 ; 1349: 162-173
114. Suchecki D, Mozaffarian D, Gross G, et al. Effects of maternal deprivation on the ACTH stress response in the infant rat. Neuroendocrinology. 1993 ; 57: 204-212 (Pubitemid 23147800)
115. Svizenska I, Dubovy P, Sulcova A. Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures-a short review. Pharmacol Biochem Behav. 2008 ; 90: 501-511
116. Thomas A, Baillie GL, Phillips AM, et al. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol. 2007 ; 150: 613-623 (Pubitemid 46355558)
117. Tullis LM, Dupont R, Frost-Pineda K, et al. Marijuana and tobacco: a major connection?. J Addict Dis. 2003 ; 22: 51-62 (Pubitemid 37465921)
118. Tyrka AR, Wier L, Price LH, et al. Childhood parental loss and adult hypothalamic-pituitary-adrenal function. Biol Psychiatry. 2008 ; 63: 1147-1154
119. Viveros MP, Llorente R, Lopez-Gallardo M, et al. Sex-dependent alterations in response to maternal deprivation in rats. Psychoneuroendocrinology. 2009 ; 34 (Suppl 1). S217 - S226
120. Viveros MP, Llorente R, Moreno E, et al. Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods. Behav Pharmacol. 2005a ; 16: 353-362 (Pubitemid 41404806)
121. Viveros MP, Marco-López EM, López-Gallardo M, et al. Framework for sex differences in adolescent neurobiology: a focus on cannabinoids. Neurosci Biobehav Rev. 2010 ;:
122. Viveros MP, Marco EM, File SE. Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav. 2005b ; 81: 331-342 (Pubitemid 40807131)
123. Viveros MP, Marco EM, File SE. Nicotine and cannabinoids: parallels, contrasts and interactions. Neurosci Biobehav Rev. 2006 ; 30: 1161-1181 (Pubitemid 44856747)
124. Viveros MP, Marco EM, Llorente R, et al. Endocannabinoid system and synaptic plasticity: implications for emotional responses. Neural Plast. 2007 ;: 52908
125. Watson S, Chambers D, Hobbs C, et al. The endocannabinoid receptor, CB1, is required for normal axonal growth and fasciculation. Mol Cell Neurosci. 2008 ; 38: 89-97
126. Wegener N, Koch M. Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment. Brain Res. 2009 ; 1253: 81-91
127. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987 ; 44: 660-669 (Pubitemid 17099795)
128. Wenger T, Gerendai I, Fezza F, et al. The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats. Life Sci. 2002 ; 70: 1407-1414 (Pubitemid 34159097)
129. Wotjak CT. Role of endogenous cannabinoids in cognition and emotionality. Mini Rev Med Chem. 2005 ; 5: 659-670 (Pubitemid 40933037)
130. Wu CS, Zhu J, Wager-Miller J, et al. Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. Eur J Neurosci. 2010 ; 32: 693-706
131. Zavitsanou K, Garrick T, Huang XF. Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2004 ; 28: 355-360 (Pubitemid 38130143)